Option Care Health Inc Stock Price, News & Analysis

Option Care Health, the largest independent national provider of home infusion services, will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022, in Las Vegas. The event will feature a fireside chat at 11:20 AM PT, with an audio replay available online afterward. Option Care Health employs over 7,000 team members, including more than 4,000 clinicians, dedicated to improving patient care for acute and chronic conditions across all 50 states. For more information, visit OptionCareHealth.com.

Option Care Health reported a robust first quarter for 2022, achieving net revenue of $915.8 million, a 20.6% increase from $759.2 million in Q1 2021. The gross profit rose to $200.9 million, representing 21.9% of net revenue. The company posted a net income of $30.3 million ($0.17 per share), recovering from a net loss of $2.9 million the prior year. Additionally, Adjusted EBITDA surged by 48.9% to $77.8 million. For 2022, guidance projects revenue between $3.75 billion and $3.90 billion.

Option Care Health (Nasdaq: OPCH) announced the acquisition of Specialty Pharmacy Nursing Network Inc. (SPNN) for $60 million in cash, finalized on April 11, 2022. This acquisition enhances Option Care's nursing capabilities, expanding its team to over 2,900 nurses nationwide. SPNN, a leader in providing specialized nursing resources, will continue its operations as a separate unit within Option Care Health. CEO John Rademacher emphasized that this move aligns with their strategy to improve infusion care and ensures future growth opportunities.

Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced its first quarter financial results will be released on April 28, 2022. The management team will host a conference call at 8:30 a.m. E.T. to discuss these results. Investors can access the call by phone or through a live audio webcast. A replay will be available for on-demand listening afterward. Option Care Health serves patients with acute and chronic conditions nationwide, employing over 7,000 team members, including more than 4,000 clinicians.

Option Care Health (Nasdaq: OPCH) reported strong financial results for Q4 and full year 2021, with net revenue increasing by 15.2% to $927.2 million in Q4, and by 13.4% to $3,438.6 million for the year. Gross profit rose to $212.2 million in Q4, and net income surged to $75.5 million, driven by a one-time tax benefit. The company also announced the acquisition of Wasatch Infusion LLC and a definitive agreement to acquire Specialty Pharmacy Nursing Network, expected to close in 2022. Full year 2022 guidance projects net revenue of $3.65 to $3.85 billion.

Option Care Health (NASDAQ: OPCH) will release its fourth quarter and full year results for 2021 on February 23, 2022, before market opens. This marks a significant reporting period for the nation's largest independent provider of home and alternate site infusion services. A conference call to discuss the results will be held at 8:30 a.m. E.T. the same day. Interested parties can access the call by dialing (866) 360-3136 or via a live audio webcast at OptionCareHealth's investor relations site.

Option Care Health Inc. (NASDAQ: OPCH) has partnered with WellSky to utilize CommonWell services, aiming for improved care coordination for over 250,000 patients annually. This initiative, set to launch in Q2 2022, will enhance interoperability across healthcare platforms, allowing referral partners to gain insights into patient care plans. The partnership will enable Option Care Health to enroll patients into the CommonWell network and facilitate health data exchange. With over 26,000 provider sites in the network, this collaboration aims to elevate health outcomes nationwide.

The Company, Riverbed|Aternity, announced the appointment of seven new directors to its Board of Directors following its recapitalization, effective December 7, 2021. These seasoned leaders bring diverse skills to enhance strategic goals and customer relationships. CEO Dan Smoot emphasized the Board's alignment with the Company's future vision and its improved financial profile. The new board members include R. Carter Pate, Steve Curts, and Patricia Hume, among others, each with significant experience in various sectors.

Option Care Health reported strong financial performance for Q3 2021, achieving net revenue of $891.9 million, a 14.1% increase from the previous year. The company's gross profit rose to $203.0 million, marking a 16.5% growth. Net income surged to $35.5 million or $0.20 per share, compared to $1.7 million or $0.01 per share in Q3 2020. Adjusted EBITDA improved by 31.7% to $78.0 million. The company maintains full-year guidance for net revenue between $3.35 billion and $3.50 billion.